BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2151064)

  • 1. Pharmacokinetics of teicoplanin in burn patients.
    Potel G; Moutet J; Bernareggi A; Le Normand Y; Meigner M; Baron D
    Scand J Infect Dis Suppl; 1990; 72():29-34. PubMed ID: 2151064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function.
    Derbyshire N; Webb DB; Roberts D; Glew D; Williams JD
    J Antimicrob Chemother; 1989 Jun; 23(6):869-76. PubMed ID: 2527223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and tissue penetration of teicoplanin.
    Novelli A; Mazzei T; Reali EF; Mini E; Periti P
    Int J Clin Pharmacol Res; 1989; 9(3):233-7. PubMed ID: 2526102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
    Mini E; Mazzei T; Reali EF; Novelli A; Periti P
    Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin pharmacokinetics in patients with severe burn injuries.
    Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
    Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis.
    Wolter K; Claus M; Wagner K; Fritschka E
    Clin Nephrol; 1994 Dec; 42(6):389-97. PubMed ID: 7882603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of melatonin against renal dysfunction following severe burn in rats].
    Han XH; Wen GQ; Xu L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):721-3. PubMed ID: 18093427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous atrial natriuretic peptide on pulmonary dysfunction and renal function following burn shock.
    Oda J; Kasai K; Noborio M; Aoki Y; Yamashita K; Inoue T; Ueyama M; Yukioka T
    J Trauma; 2009 May; 66(5):1281-5. PubMed ID: 19430227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of teicoplanin in the elderly.
    Rosina R; Villa G; Danese A; Cavenaghi L; Picardi L; Salvadeo A
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():39-45. PubMed ID: 2965130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of anakinra in subjects with different levels of renal function.
    Yang BB; Baughman S; Sullivan JT
    Clin Pharmacol Ther; 2003 Jul; 74(1):85-94. PubMed ID: 12844139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin pharmacokinetics in patients with chronic renal failure.
    Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a single dose of teicoplanin in burn patients.
    Steer JA; Papini RP; Wilson AP; Dhillon S; Hichens MF; McGrouther DA; Frame JD; Parkhouse N
    J Antimicrob Chemother; 1996 Mar; 37(3):545-53. PubMed ID: 9182111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue concentrations of ceftazidime in burn patients.
    Walstad RA; Aanderud L; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(5):543-9. PubMed ID: 3069478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 14C-teicoplanin in healthy volunteers.
    Buniva G; Del Favero A; Bernareggi A; Patoia L; Palumbo R
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():23-8. PubMed ID: 2965128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.